# BrightSpring Health (BTSG) — Analyst Forecast

BTSG · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/btsg/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 20 | 0 | 0 | 20 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $78.00 | $81.80 | $90.00 | 5 |

Last price $63.01 (as of Oct 13, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Aug 13, 2026 | BTIG | Maintained | Buy | $90.00 |
| Aug 3, 2026 | BTIG | Maintained | Buy | $90.00 |
| Jul 14, 2026 | Keybanc | Maintained | Overweight | $80.00 |
| Jul 14, 2026 | Morgan Stanley | Maintained | Overweight | $80.00 |
| Jul 13, 2026 | Wells Fargo | Maintained | Overweight | $78.00 |
| Jul 13, 2026 | Guggenheim | Initiated Coverage | Buy | $81.00 |
| Jul 10, 2026 | Raymond James | Initiated Coverage | Outperform | $80.00 |
| Jul 8, 2026 | UBS | Maintained | Buy | $85.00 |
| Jul 2, 2026 | B of A Securities | Maintained | Buy | $77.00 |
| Jun 22, 2026 | BTIG | Maintained | Buy | $90.00 |
| Jun 18, 2026 | TD Cowen | Maintained | Buy | $81.00 |
| Jun 8, 2026 | Goldman Sachs | Initiated Coverage | Buy | $71.00 |
| Jun 2, 2026 | Morgan Stanley | Maintained | Overweight | $71.00 |
| May 6, 2026 | Morgan Stanley | Maintained | Overweight | $62.00 |
| May 5, 2026 | Mizuho | Maintained | Outperform | $61.00 |
| May 4, 2026 | BTIG | Maintained | Buy | $65.00 |
| May 4, 2026 | BMO Capital | Maintained | Outperform | $60.00 |
| May 4, 2026 | Stephens & Co. | Maintained | Overweight | $64.00 |
| May 4, 2026 | Keybanc | Maintained | Overweight | $60.00 |
| May 4, 2026 | TD Cowen | Maintained | Buy | $65.00 |

## Frequently Asked Questions

### What is the price target for BTSG stock?

The average 12-month analyst price target for BrightSpring Health (BTSG) is $81.80, with a high estimate of $90.00 and a low of $78.00, across 5 analysts.

### Is BTSG a buy, sell, or hold?

Analysts covering BrightSpring Health currently average a Buy rating: 20 buy, 0 hold and 0 sell, from 20 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for BTSG?

The average price target of $81.80 implies 29.82% upside from the last price of $63.01.

### What is the latest analyst rating on BTSG?

On Aug 13, 2026, BTIG maintained BrightSpring Health at Buy with a price target of $90.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).